268 related articles for article (PubMed ID: 3129665)
1. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone.
Martinez de la Escalera G; Weiner RI
Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665
[TBL] [Abstract][Full Text] [Related]
2. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
MartÃnez de la Escalera G; Guthrie J; Weiner RI
Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
Shah GV; Wang W; Grosvenor CE; Crowley WR
Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
Delbeke D; Dannies PS
Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
[TBL] [Abstract][Full Text] [Related]
6. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
Kageyama J
Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1243-54. PubMed ID: 6440813
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of dopamine from its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion.
Martinez de la Escalera G; Weiner RI
Endocr Rev; 1992 May; 13(2):241-55. PubMed ID: 1618163
[TBL] [Abstract][Full Text] [Related]
8. Transient dopamine withdrawal differentially potentiates thyrotropin releasing hormone-induced release of prolactin of various ages.
Martinez de la Escalera G; Weiner RI
Neuroendocrinology; 1990 Jun; 51(6):694-9. PubMed ID: 2114004
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
Pu HF; Liu TC
J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
[TBL] [Abstract][Full Text] [Related]
10. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
Apfelbaum ME
Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
[TBL] [Abstract][Full Text] [Related]
11. The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats.
Haisenleder DJ; Moy JA; Gala RR; Lawson DM
Proc Soc Exp Biol Med; 1988 Mar; 187(3):341-9. PubMed ID: 3126503
[TBL] [Abstract][Full Text] [Related]
12. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
13. Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs.
Martinez de la Escalera G; Weiner RI
Endocrinology; 1988 Sep; 123(3):1682-7. PubMed ID: 2456918
[TBL] [Abstract][Full Text] [Related]
14. Regulation of glycoprotein hormone free alpha-subunit secretion and intracellular alpha-subunit content in primary pituitary cells.
Holdstock JG; Burrin JM
Endocrinology; 1994 Feb; 134(2):685-94. PubMed ID: 7507833
[TBL] [Abstract][Full Text] [Related]
15. Pituitary thyrotropin-releasing hormone (TRH) receptors: effects of TRH, drugs mimicking TRH action, and chlordiazepoxide.
Hinkle PM; Shanshala ED
Mol Endocrinol; 1989 Sep; 3(9):1337-44. PubMed ID: 2481818
[TBL] [Abstract][Full Text] [Related]
16. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity.
Ramsdell JS; Tashjian AH
Endocrinology; 1985 Nov; 117(5):2050-60. PubMed ID: 3930223
[TBL] [Abstract][Full Text] [Related]
18. Dopamine inhibits prolactin release when cyclic adenosine 3',5'-monophosphate levels are elevated.
Delbeke D; Scammell JG; Martinez-Campos A; Dannies PS
Endocrinology; 1986 Apr; 118(4):1271-7. PubMed ID: 3004906
[TBL] [Abstract][Full Text] [Related]
19. Comparison of patterns of prolactin release in GH4C1 cells and primary pituitary cultures.
Delbeke D; Kojima I; Dannies PS
Mol Cell Endocrinol; 1985 Nov; 43(1):15-22. PubMed ID: 3934015
[TBL] [Abstract][Full Text] [Related]
20. Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cells.
Matsushita N; Kato Y; Shimatsu A; Katakami H; Yanaihara N; Imura H
Life Sci; 1983 Mar; 32(11):1263-9. PubMed ID: 6132313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
